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ABSTRACT
PDIP46 (SKAR, POLDIP3) was discovered through its interaction with the p50 
subunit of human DNA polymerase δ (Pol δ).  Its functions in DNA replication are 
unknown. PDIP46 associates with Pol δ in cell extracts both by immunochemical and 
protein separation methods, as well as by ChIP analyses. PDIP46 also interacts with 
PCNA via multiple copies of a novel PCNA binding motif, the APIMs (AlkB homologue-2 
PCNA-Interacting Motif). Sites for both p50 and PCNA binding were mapped to the 
N-terminal region containing the APIMs. Functional assays for the effects of PDIP46 
on Pol δ activity on singly primed ssM13 DNA templates revealed that it is a novel and 
potent activator of Pol δ. The effects of PDIP46 on Pol δ in primer extension, strand 
displacement and synthesis through simple hairpin structures reveal a mechanism 
where PDIP46 facilitates Pol δ4 synthesis through regions of secondary structure on 
complex templates. In addition, evidence was obtained that PDIP46 is also capable of 
exerting its effects by a direct interaction with Pol δ, independent of PCNA. Mutation 
of the Pol δ and PCNA binding region resulted in a loss of PDIP46 functions.   These 
studies support the view that PDIP46 is a novel accessory protein for Pol δ that is 
involved in cellular DNA replication. This raises the possibility that altered expression 
of PDIP46 or its mutation may affect Pol δ functions in vivo, and thereby be a nexus 
for altered genomic stability.
INTRODUCTION
Genomic stability in all organisms begins with 
the process of DNA replication, which is performed by 
replicative DNA polymerases endowed with exquisite 
fidelity. An understanding of the properties and regulation 
of the replicative DNA polymerases is therefore of crucial 
significance in the context of the maintenance of genome 
stability. Thus, the mechanisms by which the high fidelity 
of DNA polymerases is achieved have been extensively 
studied [1]. In human cells, there are two proofreading 
DNA polymerases, Pol δ and Pol ε. Mutations that alter the 
properties of Pol δ and Pol ε are of direct significance as a 
potential of genomic instability [2, 3]. It is well recognized 
that defects in the proofreading abilities of DNA 
polymerases in a broad range of organisms play a crucial 
role in increased mutation rate and genomic instability [4]. 
However, it is only recently that increasing information 
on alterations of Pol δ and Pol ε that are associated with 
cancer has emerged, as evidenced in studies of colorectal 
and endometrial cancer [5, 6]. There remains a great deal 
yet to be learned about mechanisms that could affect the 
properties of the replicative polymerases and contribute to 
cancer etiology.
There has been significant progress in the study of 
human Pol δ and its regulation [7, 8]. The human Pol δ 
holoenzyme (Pol δ4) is a heterotetramer consisting of 
p125 (the catalytic subunit), p50, p68 [9], and a fourth 
subunit, p12 [10], that is not present in S. cerevisiae Pol 
δ [11]. Pol δ4 can be converted to the trimeric form (Pol 
δ3) by the proteasomal destruction of p12 in response to 
DNA damage [12, 13]. Pol δ3 is a physiologically active 
enzyme that is engaged in DNA repair [14]. Pre-steady 
state kinetic analyses of Pol δ4 and Pol δ3 have shown that 
the p12 subunit exerts a profound influence on the kinetic 
constants of Pol δ, such that Pol δ3 exhibits a decreased 
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tendency for lesion bypass, increased stalling at template 
lesions, and a greater proofreading ability through 
alteration of the rate constants for the polymerization step 
(kpol) and the translocation of the primer terminus from the 
polymerase to the 3’ to 5’ exonuclease catalytic sites (k
pol-
exo) [15, 16]. These studies have shown that the fidelity of 
Pol δ may be altered through interaction of the p12 subunit 
with the catalytic core. A balance between Pol δ4 and Pol 
δ3 appears to be required in vivo, since reduced expression 
of p12 in cancer cells is associated with an increased 
genomic instability and a poor prognosis for certain 
lung cancers [17, 18]. The example of p12 also raises a 
possibility for the existence of other protein interactors 
of Pol δ that could affect its kinetic properties, including 
processivity and fidelity. 
Pol δ3 is also formed during the normal cell division 
cycle at the G1/S transition, such that it is the predominant 
form of Pol δ during S phase [19-21], consistent with its 
having a role in DNA replication. The degradation of p12 
is mediated by the ubiquitin ligase CRL4Cdt2 [19, 22] that 
plays a major role in regulating the G1/S transition [23-
25]. We have reconstituted the human Okazaki fragment 
processing system using both Pol δ3 and Pol δ4 [26, 
27]. Both cooperate with Fen1 in removal of blocking 
primers, so that both appear to be capable of participating 
in Okazaki fragment processing but operate by different 
mechanisms for the removal of blocking oligonucleotides 
[8, 27]. 
Our laboratory has been interested in the search 
for Pol δ interacting proteins, in order to identify novel 
proteins that may be involved in regulating or augmenting 
Pol δ functions. Screening by the yeast two-hybrid 
system with the p50 subunit of Pol δ as the bait resulted 
in identification of two Pol δ binding proteins, named 
PDIP38 and PDIP46 [28]. PDIP46 was rediscovered as 
SKAR (S6K1 Aly/REF-like target) [29, 30], a target of 
ribosomal S6K1 kinase that is downstream of the mTOR 
and PI3K signaling pathways that regulate cell growth 
in response to nutritional and mitogenic signals [31]. 
SKAR has a RNA recognition motif (RRM), an abundant 
nucleic acid binding domain [32], with homology to that 
of the Aly/REF RNA binding protein that is involved in 
posttranscriptional regulatory processes and mRNA export 
[33]. Hyperphosphorylation and activation of S6K1 leads 
to its binding to SKAR and the phosphorylation of SKAR; 
this triggers the recruitment of SKAR/S6K1 to the exon 
junction complex and increases the translational efficiency 
of newly spliced mRNA [30]. Partial knockdowns of 
S6K1 or SKAR result in reduction of cell size, and slowed 
progression through S phase [29]. 
Other than the original description of the discovery 
of PDIP46 (also known as POLDIP3) [28], no information 
has emerged on the functional effects of PDIP46 on Pol δ. 
Here we report the first detailed analysis of the effects of 
PDIP46 on Pol δ function. Our studies show that PDIP46 
is associated with Pol δ in a cellular context. Mapping 
of the interaction sites of PDIP46 with p50 and PCNA 
show that both sites are located in the N-terminal region, 
and that PDIP46 interacts with PCNA via APIM motifs 
(AlkB homologue 2 PCNA-Interacting Motif) [34]. We 
performed a detailed examination of the effects of PDIP46 
on human Pol δ activity using assays that assess its ability 
for processive synthesis on long stretches of DNA, as 
well as on model oligonucleotide templates. These studies 
reveal that PDIP46 has a profound effect on the activity of 
Pol δ, and support the hypothesis that PDIP46 has a role 
in cellular DNA replication.
RESULTS
Association of PDIP46 with Pol δ
The only published information on the relationship 
between PDIP46 and Pol δ was the demonstration of the 
interaction between PDIP46 and the p50 subunit by the 
yeast two-hybrid assay [28]. We first determined that 
PDIP46 interacts with the intact Pol δ heterotetramer, 
to ascertain that this interaction is not restricted to the 
free p50 subunit used as the bait in the yeast two-hybrid 
screen. This was established by the use of GST-PDIP46 
pull-down assays, which demonstrated that all four 
subunits of the Pol δ4 were pulled down (Figure 1A). This 
interaction was also demonstrated in HeLa cell lysates by 
immunoprecipitation with polyclonal antibodies against 
PDIP46, where both the p50 and p125 subunits of Pol 
δ were pulled down (Figure 1B). The latter result does 
not necessarily show a direct interaction, since, as will be 
shown below, PDIP46 also interacts with PCNA. However, 
a more stringent immunochemical demonstration of the 
association between PDIP46 was performed, by showing 
that PDIP46 could be detected in the fractions from the 
immunoaffinity chromatography of HeLa cell lysates on 
immobilized p125 antibody; PCNA is not bound to this 
column (Figure S1, Supplementary Data). 
We also determined whether association of PDIP46 
with Pol δ could be observed by the formation of higher 
molecular weight complexes in cultured cell extracts. 
Nuclear extracts of HEK 293 cells were chromatographed 
on a Sepharose 6 gel filtration column (Figure 1C). 
PDIP46 co-eluted in the same fractions as p125, in a 
region where the ferritin marker (Mr 440,000) eluted. 
(Two bands are found for PDIP46 by Western blotting; 
these bands likely represent the full-length PDIP46 
and its smaller alternatively spliced variant [29]). In 
previous studies, purified recombinant Pol δ4 was found 
to behave with a molecular weight (232,000-280,000) 
consistent with its estimated molecular mass [35]. HEK 
293 cell lysates were also subjected to nondenaturing gel 
electrophoresis on gradient gels, under conditions where 
the gels are run until limiting mobility is reached due to 
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pore size (Figure 1D). We had previously shown that Pol 
δ in cultured cell extracts migrates at a position similar to 
thyroglobulin (Mr 669,000). As seen in Figure 1D, both 
the p125 subunit of Pol δ and PDIP46 co-migrate at a 
position similar to thyroglobulin (Mr 669,000). Together, 
these experiments support the idea that PDIP46 associates 
with Pol δ in a cellular context. 
Association of PDIP46 with Pol δ on chromatin as 
determined by ChIP analysis
An important step for establishing a role of 
PDIP46 in DNA replication is the determination of 
whether it is bound to chromatin in association with 
Pol δ and other replication proteins. We performed 
chromatin immunoprecipitation of HeLa cells, using 
an antibody against p125 [14], and immunoblotted for 
PDIP46. PDIP46 was co-immunoprecipitated with p125 
by ChIP analysis (Figure 2A). As a positive control, we 
performed the same ChIP analysis and blotted for two 
proteins associated with the replication fork, Mcm2 and 
Ctf4 (Figure 2B). Mcm2 is a subunit of the Mcm2-7 
helicase that together with Cdc45 and the GINS complex 
form the CMG replicative helicase in yeast [36] and 
humans [37,38]. Ctf4 (chromosome transmission fidelity 
4) is important for sister chromatid cohesion and DNA 
Figure 1: Association of PDIP46 with Pol δ by co-immunopreciptation, gel filtration, and native gradient gel 
electrophoresis. A. PDIP46 interacts with the Pol δ4 holoenzyme. GST-PDIP46 (GST-p46) was used to pull-down purified Pol δ. The 
pull-downs were western blotted for the p125, p68, p50, and p12 subunits of Pol δ. B. Co-immunoprecipitation of PDIP46 with Pol δ. HeLa 
cell extracts were immunoprecipitated with antibodies against PDIP46, and western blotted for the p50 (left panel) and p125 subunits (right 
panel) of Pol δ. C. Nuclear extracts of HEK 293 cells were chromatographed on a Superose 6 FPLC column as previously described [35]. 
Column fractions were western blotted for p125 and PDIP46. “BC” refers to the nuclear extract. Positions of molecular weight standards 
are shown on the left. The arrows refer to the elution of protein standards (Mr: thyroglobulin, 669,000; ferritin, 440,000; aldolase, 158,000). 
D. HEK 293 cell lysates were subjected to native (nondenaturing) gradient gel electrophoresis until limiting mobility was reached. Proteins 
were transferred to nitrocellulose membranes and Western blotted for p125 and PDIP46 (Materials and Methods). The migration positions 
of marker proteins (thyroglobulin, ferritin and catalase) and their respective native molecular weights are shown on the left. 
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replication; it associates with the CMG helicase and 
interacts with the replicative polymerases, most strongly 
to Pol α, pointing to a role in replisome assembly [39, 
40]. Taken together with data of Figure 1, these results 
provide evidence that PDIP46 is associated with Pol δ at 
the replication fork on chromatin. 
Mapping of the interaction domains between p50 
and PDIP46
The region of p50 involved in PDIP46 interaction 
was mapped using pull-down assays by the use of 
GST-p50 deletion constructs to pull down his-tagged 
PDIP46 (Figure 3A). This was shown to be between 
residues 252-400 of p50. The interaction domain of 
PDIP46 for binding to p50 was also mapped by the use 
of GST-fusion deletion constructs of PDIP46 to pull down 
his-p50 (Figure 3B). A diagram of the mutants that pulled 
down his-p50 showed that the binding region on PDIP46 
for p50 lies between residues 71-141 in the N-terminus 
(Figure 3C, shaded region). 
PDIP46 interacts with PCNA: identification 
of PDIP46 as a novel member of the group of 
proteins that interact with PCNA via APIM motifs
We found that PDIP46 also interacts with PCNA. 
Three GST-PDIP46 fusion constructs were used to 
perform pull-down assays of PCNA. Only the full-length 
PDIP46 and the N-terminal fragment (residues 1-141) 
were able to pull-down PCNA (Figure 4A). PCNA-
binding partners generally possess a PIP-box, a short 
protein motif that binds to a hydrophobic pocket on PCNA 
[41,42]. However, inspection of this N-terminal region (or 
the entire PDIP46 sequence) did not reveal any sequences 
corresponding to a canonical PIP-box. The N-terminal 
sequence harbors five repeats of a short sequence (Figure 
Figure 2: PDIP46 is associated with chromatin bound 
Pol δ by ChIP analysis using antibody against p125. 
ChIP analysis was performed with A549 cells as described in 
“Materials and Methods”. A. The immunoprecipitates were 
western blotted with antibodies against PDIP46 and the p125 
subunit of Pol δ. IgG refers to the control immunoprecipitation 
with non-immune serum. The bands marked “α” and “β” refer to 
the full-length PDIP46 and its minor spliced variant, respectively. 
B. ChIP analysis was performed as in (A) and western blotted for 
MCM2 and Ctf4 which were used as positive controls. 
Figure 3: Mapping of the interaction sites between p50 
and PDIP46. A. Mapping of the region of p50 that interacts 
with PDIP46. GST-fusion constructs of p50 were used to pull-
down his-PDIP46, and western blotted for PDIP46. Only the 
deletion mutant containing residues 252-400 of p50 interacted 
with PDIP46. B. Mapping of the PDIP46 region that interacts 
with the p50 subunit of Pol δ. GST-PDIP46 deletions were used 
for pull-down assays of his-p50, and western blotted for p50. 
C. Diagrammatic summary of the data of panel B. Solid bars 
show those deletion constructs that interacted with p50, and the 
dashed lines show those that did not. The shaded area shows the 
common region of the PDIP46 deletion mutants that interacted 
with p50 (residues 71-141).
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4B) which we identified as members of an alternative 
PCNA binding motif [34], the APIM (AlkB homologue 
2 PCNA-Interacting Motif). The APIM consists of five 
residues with the consensus sequence [KR]-[FYW]-
[LIVA]-[LIVA]-[KR] and was initially identified as 
a novel PCNA binding motif in human oxidative 
demethylase ABH2 (AlkB homologue 2), a DNA repair 
enzyme [34]. Bioinformatics searches identified over 
200 human proteins that contain APIMs; these include 
many proteins that are involved in genomic maintenance 
(DNA repair, DNA replication and cell cycle control) 
[34]. However, functional PCNA binding by APIMs 
has been demonstrated in only seven proteins to date - 
ABH2, the transcription factor TFII-I, Topo IIα, Rad51B, 
TFIIS-L [34], the nucleotide excision repair protein XPA 
[43], and the F-box helicase, FBH1, that is involved in 
homologous recombination [44]. The alignment of the 
APIMs of PDIP46 with those of these seven proteins show 
that they conform to the motif, with the exceptions of the 
conservative replacements of phenylalanine with leucine 
or isoleucine in three of the motifs (APIMs 2,3,5), and 
all have additional variations in the aliphatic residues of 
positions 3 or 4 (Figure 4B). A BLAST (tblastn) search 
showed that the region (residues 50-130) containing all 
five PDIP46 APIMs is almost completely conserved in 
mammalian species, while the full-length sequence is 
>90% conserved. PDIP46, while highly conserved in 
higher vertebrates, does not appear to be present in lower 
vertebrates [29].
In order to demonstrate that the APIMs are 
Figure 4: PDIP46 interacts with PCNA, and does so via APIM motifs. A. Mapping of the PDIP46 domain that interacts with 
PCNA. GST-PDIP46 deletion mutants were used to pull-down PCNA, and western blotted for PCNA. Only the GST-1-141 fusion protein 
interacted with PCNA. B. The N-terminus of PDIP46 harbors 5 APIM motifs. The alignment shows the five APIM motifs of PDIP46, 
together with those of the oxidative demethylase ABH2, the four APIMs of TFII-I, Topo IIα, Rad51B and TFIIS-L [34], FBH1 (F-box 
helicase) [44] and XPA [43]. Residues in red show the conserved basic residues at positions 1 and 5, as well as the phenylalanine at position 
2, while those in blue are the aliphatic residues at positions 3 and 4. All sequences shown are those of human proteins. C. Mutation of 
the APIMs of PDIP46 leads to loss of PCNA binding. The conserved residues in positions 1, 2 and 5 of the APIM motifs were mutated to 
alanines (PDIP46-5A). GST-PDIP46 and the GST-PDIP46-5A mutant were used in pull-down assays of PCNA. D. Mutation of the APIMs 
of PDIP46 also leads to loss of p50 binding. GST-PDIP46 and the GST-PDIP46-5A mutant were used in pull-down assays of his-p50. E. 
Domain map of PDIP46 showing the location of binding regions (boxed) for p50, PCNA (APIM motifs), RRM, and S6K1. The two S6K1 
phosphorylation sites and the region deleted in a minor splice variant [29] are also shown.
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functionally responsible for the binding of PCNA by 
PDIP46, we took the approach of mutating all five of 
the motifs to generate the PDIP46-5A mutant to avoid 
the complexity that might arise from the ability of the 
individual motifs to bind PCNA. Residues at positions 
1 (R/K), 2 (F/L/I) and 5 (R/K) in all five of the APIMs 
(Figure 4B) were mutated to alanines. GST-PDIP46 and 
GST-PDIP46-5A were used to pull-down PCNA (Figure 
4C). PDIP46-5A exhibited near complete loss of PCNA 
binding. These results eliminate the involvement of a 
variant PIP-box elsewhere in PDIP46, noting that Topo IIα 
[34] and FBH1 [34] possess both APIMs and PIP-boxes. 
More detailed mutational analyses will be needed to 
determine which of the five APIMs of PDIP46 are needed 
for the interaction with PCNA. However, it is noted that 
the first four APIMs are tightly clustered, with the spacing 
being 10, 4, 2 and 32 amino acid residues between the 
five APIMs so that there may be spatial or conformational 
constraints on which of these interact with PCNA. 
These data narrow down the region involved in 
PCNA binding to the region containing the five APIMs 
(residues 53 to 125). This closely overlaps the region 
of PDIP46 for p50 binding (residues 71-141) that was 
mapped by deletion mutagenesis (Figure 3C). The 
possibility that mutation of the APIMs might also affect 
p50 binding was considered. This was indeed found to 
be the case, as the PDIP46-5A was found to have lost 
the ability to bind to p50 (Figure 4D). This allows the 
delimitation of the p50 binding region from residues 
71-141 (Figure 3B, 3C) to residues 71-125. Thus, the 
PDIP46-5A mutant is one that has lost interaction with 
both PCNA and Pol δ. 
The location of the APIMs, PCNA and Pol δ binding 
regions are shown diagrammatically in the domain map 
of PDIP46 (Figure 4E). Both the p50 and PCNA binding 
regions of PDIP46 are located in the N-terminus, while 
the binding region for S6K1, which is important for its 
functions as the SKAR protein, are in the C-terminus 
within the RRM. The separation of the interaction sites 
for p50 and PCNA and the RRM are significant as they 
are consistent with the idea that PDIP46/SKAR is a 
bifunctional protein. 
PDIP46 is a potent activator of Pol δ4 in primer 
extension assays which require highly processive 
synthesis





 as the substrate. This assay 
is commonly used for the assay of Pol δ activity. In this 
assay Pol δ was inhibited with half maximal inhibition at 
about 1 µM of PDIP46. The inhibition could be relieved 
by increasing the concentration of PCNA (Figure S2, 
Supplementary Data), indicating a competition between 
Pol δ and PDIP46 for PCNA. Such effects are likely to be 
non-physiological, given the concentration levels needed, 
and are not unexpected as they could be observed with 
any other PCNA binding protein. In previous studies 
of PDIP38, which also binds PCNA, we observed that 





 as the substrate [45]. These effects 
occurred at micromolar levels of PDIP38, and are likely 
due to competition with Pol δ for PCNA. 
 We re-assessed the effects of PDIP46 using singly 
primed M13 DNA as the substrate (Figure 5A). The single 
stranded M13 DNA is ca. 7 kb in size, and presents a more 
complex template than the homopolymeric poly(A)
4000
 
used in the poly(dA)/oligo(dT) assay, as it contains 
regions of secondary structure. This assay has been used to 
examine the ability of Pol δ/PCNA to perform processive 
synthesis to the full-length products of ca. 7 kb [46], and 
is regarded as an quasi-reconstitution assay that provides 
an in vitro assessment of Pol δ capability in leading strand 
synthesis in a processive manner [35, 38, 47, 48]. PCNA 
is first loaded onto the primed M13 DNA by its clamp 
loader, RFC, in the presence of RPA and ATP (Figure 5A). 
Pol δ activity in this assay is dependent on the addition of 
RPA single stranded binding protein [46]. 
PDIP46 was found to be a potent stimulator of 
formation of the full-length 7 kb product by Pol δ4. The 
formation of products at or near full-length extension of 
the primer is dramatically increased by PDIP46 within a 
concentration range from 0-150 nM (Figure 5B). Analysis 
of product formation in the 7 kb range showed that the 
reactions displayed saturation kinetics with increasing 
concentration of PDIP46, and at the highest concentration 
used, this amounted to a >10 fold increase in product 
formation (Figure 5C). The data were fitted to a one site 
binding hyperbola, giving an apparent KD of 34 ± 7.7 nM 
(R2 = 0.98) (Figure 5C). 
The time course of the formation of full-length M13 
DNA in the presence of 20 nM PDIP46 is shown in Figure 
5D. Even at 20 nM, PDIP46 dramatically accelerates 
the formation of the full-length M13 products by Pol δ4 
(Figure 5D, 5E). 
With regard to our previous observations of an 
inhibitory effect of PDIP46 in the poly(dA)/oligo(dT) 
assay, we could also observe inhibition when we used 
high concentrations of PDIP46 (Figure 5F, 5G). We re-
examined the effects of PDIP46 on Pol δ activity in 
the poly(dA)/oligo(dT) assay using a lower range of 
concentrations, but were unable to detect any stimulation 
of Pol δ activity (data not shown). It is noted that the 
template in this case is a homopolymer, and lacks any 
sequence complexity.
The effects of increasing Pol δ4 levels in the absence 
and presence of a fixed PDIP46 concentration (100 nM) 
were examined (Figure S3A, S3B, Supplementary Data). 
Product formation was quantitated for the major products 
in the 3-7 kb range as well as for the 7 kb range (Figure 
S3C,D, Supplementary Data). In both cases, apparent 
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Figure 5: PDIP46 stimulates product formation by Pol δ4 in the M13 assay. A. Diagram of the M13 assay of Pol δ activity. 
Singly primed M13 ssDNA (left) is loaded with PCNA with RFC, and RPA single stranded DNA binding protein (center); Pol δ4 and 
[α-32P]-dATP is added to extend the primer up to the full-length product (right). B. Effects of increasing concentrations of PDIP46 on Pol δ4 
activity. Pol δ4 concentration was 5 nM, M13 ssDNA was 2.5 nM, and PCNA was 6 nM (Materials and Methods). Reactions were incubated 
at 37° C for 25 min. Products were analyzed by electrophoresis on 1.2% alkaline agarose gels and were visualized by phosphorimaging. 
Lane M shows the migration of the markers. The bracket on the top left indicates the region that was used for quantitation of full-length 7 kb 
products. The asterisks show bands where pausing of the reactions occurred. C. Full-length product formation for panel B was quantified, 
and plotted as relative product formation against PDIP46 concentration. The data were fitted to a one site binding hyperbola using Prism 
software, and gave an apparent KD of 34 ± 7.7 nM (R
2 = 0.98). D. Time dependence of product formation by Pol δ4 in the M13 assay in the 
presence of PDIP46. Pol δ4 (10 nM) was assayed on singly primed M13 in the absence (left panel) and presence (right panel) of PDIP46 
(20 nM); the reactions were analyzed after 5, 10, 15, 20, 25 and 30 min. E. Product formation of the full-length products in panel D was 
quantified, and plotted as relative product formation against time. Data in the absence of PDIP46 are shown as circles, and those in the 
presence of 20 nM PDIP46 are shown as squares. F. The effects of higher concentrations (0-400 nM) of PDIP46 on Pol δ (20 nM) assayed 
on the M13 substrate. Reaction times were 15 min. G. The full-length products for panel F were quantified and plotted against PDIP46 
concentration.
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saturation of the product formation was observed, that 
was increased in the presence of PDIP46. This result is 
consistent with the possibility that there may be an effect 
on the intrinsic activity of Pol δ. 
Overall, our findings show that PDIP46 exhibits a 
remarkable ability to stimulate product formation by Pol 
δ4, by as much as an order of magnitude. While human 
Pol δ4 is capable of processive synthesis on M13 ssDNA 
templates in the presence of PCNA, it has been reported 
to dissociate frequently [38,49], and differs from yeast Pol 
δ which is highly processive [48], i.e., its processivity is 
not such that it can synthesize the entire M13 DNA in a 
single binding event. This is evident in that M13 DNA 
possesses regions of secondary structure that give rise 
to observable pause sites (Figure 5B, asterisks). These 
pause sites represent the slowing of Pol δ synthesis 
through these regions. Facilitation of Pol δ synthesis 
through these regions could contribute to an increase in 
apparent processivity of Pol δ. The stimulation of product 
formation by PDIP46 could be caused by contributions 
of several mechanisms that include direct activation of 
Pol δ, an actual effect on processivity, or the ability to 
facilitate Pol δ elongation through regions of secondary 
structure. Further complexities involved in understanding 
how PDIP46 affects Pol δ activity arise because it binds to 
both Pol δ and with PCNA and has the potential to act as a 
bridge to stabilize their interaction on DNA.
PDIP46 stimulates primer extension by Pol δ on 
model oligonucleotide substrates
In order to further explore the effects of PDIP46 on 
Pol δ4 activity and to gain insights on its potential mode 
of action, we examined its effects using oligonucleotide 
substrates, identical to those we had previously utilized for 
the reconstitution of human Okazaki fragment processing 
[26, 27]. The component reactions include primer 
extension as well as strand displacement reactions. The 
oligonucleotide substrate consisted of a 5’ end-labeled 
34mer annealed to a 70mer template (Figure 6A). We also 
tested the PDIP46-5A and PDIP46-∆RRM mutants to 
establish that the functional effects resided in the binding 
regions for Pol δ and PCNA. The PDIP46-∆RRM mutant 
is one in which the RRM domain (residues 280-351) in the 
C-terminus were deleted. Here, we were concerned that 
Figure 6: PDIP46 and PDIP46-∆RRM but not 
PDIP46-5A stimulate primer extension by Pol δ4 on 
oligonucleotide substrates in the absence of PCNA. A. 
Oligonucleotide substrate for primer extension. A 5’-[32P]end-
labeled 34mer primer was annealed to a 70mer template. The 
asterisk denotes the labeling. B. Effects of PDIP46 and PDIP46-
5A (50 nM) on primer extension by Pol δ4 in the absence of 
PCNA. The concentration of reactants were DNA substrate 
(100 nM), Pol δ4 or Pol δ3 (5 nM), PDIP46, PDIP46-∆RRM 
or PDIP46-5A (50 nM). The reactions were performed for 
times ranging from 0-10 min. Reaction products were resolved 
by electrophoresis on sequencing gels and visualized by 
phosphorimaging (Materials and Methods.). C. The full-length 
70mer primer extension products for panel B were quantified 
and plotted (as % of primer converted to 70mer) against time. 
Data for Pol δ4 in the absence of PDIP46 is shown as solid 
circles, with PDIP46 as solid squares, with PDIP46-∆RRM as 
shaded diamonds and with PDIP46-5A as shaded triangles. D. 
Effects of PDIP46 and PDIP46-5A on Pol δ3 activity in the 
absence of PCNA. Reactions were performed as described in B. 
The vertical bracket on the gel show a region of primer extension 
that is increased in the presence of PDIP46. 
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the RRM motif, which binds RNA, is also able to bind 
ssDNA, and could have a potential effect on Pol δ.
The effects of PDIP46 on Pol δ4 were first 
examined in the absence of PCNA. Pol δ4 produced 
a ladder of products, as expected from a distributive 
mode of synthesis. PDIP46 strongly increased formation 
of full-length 70mer extension products (Figure 6B, 
6C). Removal of the RRM did not affect the ability of 
PDIP46 to stimulate Pol δ4 activity. Mutation of the 
APIMs abolished the effects of PDIP46, showing that the 
functional effects are due to Pol δ interaction. The ability 
of PDIP46 to activate Pol δ4 in the absence of PCNA 
provides clear evidence that there is a direct effect on Pol δ 
activity, independent of the presence of PCNA. While the 
action of Pol δ in the context of its functions in replication 
require its interaction with PCNA, these findings are 
highly significant in the context of understanding the 
mechanism of the effects of PDIP46 on Pol δ. This is 
because the properties of Pol δ are dictated by a complex 
kinetic scheme [7, 16] shared by other replicative DNA 
polymerases [1, 50-52]. Alterations in these kinetic 
constants can not only alter steady state activity, but also 
fidelity and processivity [50]. 
We examined the effects of PDIP46 on Pol δ3 
(Figure 6D). In the absence of PCNA, Pol δ3 activity is 
lower than that of Pol δ4, and is only weakly stimulated 
by PDIP46. This effect is abolished in the PDIP46-5A 
mutant, confirming that the effects are due to PDIP46. 
The effects of PDIP46 on Pol δ4 in the presence of 
PCNA were examined. For these experiments the same 
substrate was used, but the biotinylated template ends 
were blocked with streptavidin (Figure 7A) and PCNA 
was loaded with RFC [27]. Primer extension by Pol δ4 was 
markedly stimulated by PCNA alone, as expected, with 
the shift to processive synthesis seen by the appearance 
of the full-length extension products even at the earliest 
time points (Figure 7B, left panel). PDIP46 nevertheless 
further stimulated Pol δ4 as shown by quantitation of the 
70mer full-length products. As with the primer extension 
experiments in the absence of PCNA (Figure 6B), no 
effects of the deletion of the RRM domain were seen, 
while the PDIP46-5A lost the ability to stimulate Pol δ4 
(Figure 7B, 7C). 
The smaller stimulation by PDIP46 in the presence 
of PCNA compared to those in the absence of PCNA may 
be due to the overriding effects of PCNA. (We have also 
used the unblocked template, and have obtained essentially 
similar results, consistent to our previous observations 
[27]. These findings also eliminate the possibility that 
PDIP46 affects the loading of PCNA by RFC.) 
Effects of PDIP46 on strand displacement by Pol 
δ on a model oligonucleotide substrate
The effects of PDIP46 on strand displacement by Pol 
δ4 were examined using a 70mer oligonucleotide template 
with a 5’-[32P]end-labeled 34mer primer and a 31mer 
blocking sequence (Figure 8A) [27]. On this substrate, 
Pol δ rapidly extends the 34mer primer to fill in the 5nt 
gap to form a 39mer and then stalls on encountering the 
5’ end of the blocking oligonucleotide. Further primer 
extension then requires displacement of the blocking 
oligonucleotide, which takes place at a slower rate, and 
Figure 7: Effects of PDIP46, PDIP46-∆RRM 
and PDIP46-5A on primer extension by Pol δ on 
oligonucleotide substrates in the presence of PCNA. A. 
Oligonucleotide substrate for primer extension. A 5’-[32P]end-
labeled 34mer primer was annealed to a 70mer template, and 
was then blocked with streptavidin (shaded sphere). PCNA was 
then loaded onto the substrate with RFC. B. Effects of PDIP46 
and PDIP46-5A (50 nM) on primer extension by Pol δ4 in the 
presence of PCNA. The concentrations of reactants were DNA 
(50 nM), Pol δ4 (10 nM), PCNA (50 nM), PDIP46 or its mutants 
(50 nM). Conditions used were as described in Materials and 
Methods. The reactions were performed for times ranging from 
0-10 min. Reaction products were resolved by electrophoresis 
on sequencing gels and visualized by phosphorimaging. C. 
Amounts of 70mer formed in panel B were determined and 
plotted against time. Data for Pol δ4 in the absence of PDIP46 
is shown as solid circles, with PDIP46 as solid squares, with 
PDIP46-∆RRM as shaded diamonds and with the PDIP46-5A 
mutant as shaded triangles.
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provides an assay for strand displacement. Negligible 
strand displacement occurred in the absence of PCNA 
(Figure 8B), consistent with our previous observations 
that strand displacement by Pol δ4 is dependent on the 
presence of PCNA [27]. PCNA markedly stimulated 
strand displacement, giving rise to a ladder of intermediate 
products and the formation of the 70mer (Figure 8C, left 
panel). Quantitation of the 70mer strand displacement 
product or of the combined strand displacement products 
between the 40-70mer (Figure 8D, 8E) shows quite clearly 
that strand displacement is stimulated by PDIP46. These 
effects were lost when the PDIP46-5A was used. Pol δ3 
itself has no significant strand displacement activity [27] 
and was not significantly affected by PDIP46 in this assay 
(data not shown). 
Figure 8: PDIP46 stimulates strand displacement by Pol δ4. A. Oligonucleotide substrate for primer strand displacement assays. 
A 5’-[32P]end labeled 34mer primer was annealed to a 70mer template as in Figure 6, together with a downstream blocking 31mer to 
leave a 5nt gap. The asterisk denotes the labeling. The concentration of reactants were DNA template (100 nM), Pol δ4 (5 nM), PDIP46 
or PDIP46-5A (50 nM), and PCNA (100 nM) when added. Reactions were performed for the indicated times. B. Effects of PDIP46 and 
PDIP46-5A (50 nM) on strand displacement by Pol δ4 in the absence of PCNA. Reaction products were visualized by phosphorimaging. 
C. Effects of PDIP46 and PDIP46-5A on strand displacement by Pol δ4 in the presence of PCNA. Reaction products were visualized by 
phosphorimaging. D. The 70mer full-length primer extension products for C, reflecting complete strand displacement of the blocking 
31mer oligonucleotide, were quantified and plotted as 70mer formed as % of primer against time. Data points in the absence of PDIP46 are 
shown as solid circles, with PDIP46 as solid squares, and with PDIP46-5A as shaded triangles. E. The overall strand displacement products 
as reflected by primer extension products from the 40mer-70mer (indicated by the bracket in C) were quantified and plotted against time. 
Data points were labeled as for panel D.
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PDIP46 enhances the ability of Pol δ4 to 
synthesize through a model oligonucleotide 
substrate with a hairpin secondary structure
The ability of PDIP46 to stimulate strand 
displacement activity by Pol δ4 provides insights into its 
potential mode of action when considering the effects on 
Pol δ4 function in the context of complex templates such 
as M13 ssDNA template, viz., that PDIP46 might facilitate 
synthesis by Pol δ through regions of secondary structure 
that involve simple stem-loop or hairpin structures. The 
model substrate consisted of a 64mer template, with a 
3’-biotin tag (Figure 9A, “I”). The 5’-end of the template 
contained a complementary region of 16 nt to form a 
short stem, and followed by 8 non-complementary nts 
to form a loop. To this was annealed a 5’-[32P] labeled 
primer, leaving a gap of 5 nt. Streptavidin was used to 
cap the 3’-biotinylated template end to prevent PCNA 
from sliding off after it was loaded with RFC [27]. The 
expected progress of the reaction is shown in a stepwise 
manner in Figure 9A, to illuminate the analogy with 
the strand displacement reactions of Pol δ [27]. Pol δ is 
expected to rapidly extend the primer to fill in the gap 
until 5’ end of the stem is reached (Figure 9A, “II”). The 
further process of synthesis through the stem is analogous 
to strand displacement, noticing that in the process a flap 
is formed, as the stem region is shortened, giving rise to a 
familiar stem-loop arrangement (Figure 9A, “III”). Once 
Pol δ has traversed the stem region (Figure 9A, “IV”) the 
hairpin is opened and Pol δ is expected to rapidly complete 
synthesis to the end of the template (Figure 9A, “V”). 
The results of the experiment show that Pol δ4 
performs synthesis through the hairpin as predicted as can 
be seen from the gel (Figure 9B). The gap filling is rapid, 
so that the 19mer is largely converted to the 24mer within 
the first time point. This is followed by the formation of a 
ladder of products arising from a slower progression in a 
process of strand displacement, and a more rapid reaction 
once the stem region is passed as seen by the absence of 
intermediates. Quantitation of the phosphorimage showed 
that PDIP46 (50 nM) readily stimulated the rate of Pol δ 
synthesis through the hairpin, by a factor of ca. 3.6 fold 
(Figure 9C). [This is also evident from the disappearance 
of the 24mer in the presence of PDIP46 (Figure 9B)]. The 
effects of higher concentrations of PDIP46 were examined. 
Here, as with the M13 substrate, PDIP46 was inhibitory at 
high concentrations (Figure S4, Supplementary Data). 
We examined the behavior of the PDIP46-∆RRM 
mutant (Figures 9D, 9E). The PDIP46 stimulation of Pol 
δ4 on the hairpin substrate was found to be independent of 
the RRM motif. The ability of PDIP46 to stimulate strand 
displacement and synthesis through hairpin structures 
may underlie its effects on Pol δ4 synthesis in the M13 
assay. We also performed a similar experiment with Pol 
δ3 (Figure S5, Supplementary Data). The rate of 64mer 
product formation by Pol δ3 was very minimal, about 2% 
that of Pol δ4. Nevertheless, PDIP46 increased this by ca. 
4-fold. An increase in activity with the PDIP46-∆RRM 
was observed but this may not be significant due to the 
low levels of activity. 
It is noted that the model of the reactions 
(Figure 9A) illustrates that passage through the stem 
region is a reaction that bears resemblance to strand 
displacement. Comparison of the rates of synthesis in 
strand displacement (Figure 8D), in which the Pol δ4 
concentration was half that used in Figure 9E, shows that 
the rates of synthesis are roughly comparable in terms of 
full length products formed. 
These experiments suggest a hypothesis whereby 
the ability of PDIP46 to stimulate Pol δ4 synthesis of 
the full length M13 substrate can be explained by the 
cumulative effect of the facilitation of Pol δ4 synthesis 
through multiple regions of secondary structures. This is 
presented in more detail in the Discussion.
DISCUSSION
Characterization of PDIP46 interactions with Pol 
δ and PCNA
The studies reported here provide the first detailed 
examination of the interaction of PDIP46 with Pol δ 
and PCNA and of its functional effects on Pol δ activity. 
We established that PDIP46 is associated with Pol δ in 
cellular extracts by classical protein separation and 
immunochemical procedures (Figure 1) and that PDIP46 
is associated with Pol δ by ChIP analysis with anti-p125 
antibody, providing direct evidence that PDIP46 is 
chromatin bound in the spatial proximity of Pol δ (Figure 
2). These observations support the hypothesis that PDIP46 
interaction with Pol δ is functionally meaningful in terms 
of a role in DNA replication. 
Detailed analysis of the interaction sites of PDIP46 
for the p50 subunit of Pol δ and PCNA, established that 
these located in the N-terminus (Figures 3, 4). PDIP46 
was shown to be a novel member of a group of proteins 
that interact with PCNA via APIM motifs [34]. Studies 
using mutants of PCNA in the PIP-box domain and FRET 
analyses have provided some evidence that the APIMs 
may bind to the same hydrophobic pocket of PCNA as the 
PIP-box [53], so that competition between PCNA binding 
proteins that utilize a PIP-box may occur. However, the 
biochemical or structural basis of the interaction of the 
APIM motif with PCNA has yet to be determined. Further 
studies are required to determine which of the PDIP46 
APIM motifs are functionally involved in PCNA binding.
Mutation of all five APIMs leads to loss of both 
p50 and PCNA binding. This established that the 
functional effects of PDIP46 are dependent on p50 and 
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Figure 9: PDIP46 stimulates primer extension by Pol δ4 through a template with a hairpin. A Diagram of the substrate and 
expected progression through the stem loop structure. For details see text. B. Pol δ4 (15 nM) was reacted for the indicated times with the 
substrate (50 nM) in the absence and presence of PDIP46 (50 nM) after the loading of PCNA with RFC (Experimental Procedures). The 
products were analyzed by 8M urea denaturing polyacrylamide gel electrophoresis and visualized by phosphorimaging. The arrowheads 
indicate the positions of the primer (19nt), the position at the point of primer extension to the 5’-end of the template at the start of the hairpin 
(24nt), and the full-length product (64nt). C. The amounts of 64mer representing synthesis through the hairpin for the phosphorimage in B 
were quantified. Data are plotted as percentage of primer converted in the absence (solid circles) and presence (solid squares) of PDIP46. D. 
The RRM region is not required for PDIP46 stimulation of Pol δ4. The effects of PDIP46 and the PDIP46-∆RRM mutant were examined. 
The concentrations of the reactants were DNA (50 nM), Pol δ4 (10 nM), and PDIP46 or PDIP46-∆RRM (50 nM). E. Formation of the 
64mer for panel D was quantified and plotted against time. Data for the control are shown as solid circles, for PDIP46 as solid squares, and 
for PDIP46-∆RRM as solid diamonds. 
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PCNA binding (Figure 4). Studies of the PDIP46-∆RRM 
mutant show that the effects of PDIP46 on Pol δ4 are 
independent of the RRM domain associated with the 
functions of PDIP46 studied as the SKAR protein (Figures 
6, 7). This demonstration provides a physical basis for the 
bifunctional nature of PDIP46. Further work is needed to 
determine the exact location of the p50 binding region of 
PDIP46, in order for studies that might lead to generation 
of mutations that have lost either PCNA or p50 binding.
Insights from studies of PDIP46 activity using 
model substrates: a working hypothesis for the 
mechanism of stimulation of Pol δ4 activity on 
singly primed ssM13 DNA via PDIP46 facilitation 
of bypass synthesis through secondary structures
The major and critical outcome of our studies is the 
discovery that PDIP46 has a profound effect on Pol δ4 
activity, which is evident when its effects are examined 
in assays of primer elongation on singly primed ssM13 
DNA. PDIP46 causes an elevation (ca.10-fold) of Pol δ4 
activity, which is manifested at low concentrations with an 
apparent KD of ca 34 nM (Figure 5). 
The experiments using oligonucleotide substrates 
have provided significant insights into the potential 
mechanisms that underlie the ability of PDIP46 to 
stimulate synthesis of full-length products in the 
M13 assay by Pol δ. A summary of the results of the 
oligonucleotide experiments is shown diagrammatically in 
Figure 10. The ability of PDIP46 to affect primer extension 
in the absence of PCNA unequivocally shows that this 
is mediated via a direct interaction with Pol δ4 (Figure 
10A, 10B). In the presence of PCNA, Pol δ4 synthesis is 
greatly stimulated, but is nevertheless further stimulated 
by PDIP46 (Figure 10C, 10D). In this instance, we cannot 
distinguish whether this stimulation is solely due to an 
effect on Pol δ, or whether it also involves its ability to 
bind PCNA, as the PDIP46-5A mutation abrogates both 
p50 and PCNA binding. The detailed mechanism(s) for 
the ability of PDIP46 to directly stimulate Pol δ remain 
to be determined by more intensive kinetic studies, such 
as pre-steady state kinetic analysis, since this could define 
changes in Pol δ at the catalytic level. 
PDIP46 significantly stimulates the ability of Pol 
δ4 for bypass synthesis through a model hairpin template 
(Figure 10E, 10F). This provides an explanation of why 
PDIP46 so strongly facilitates synthesis on the more 
complex M13 ssDNA template (Fig. 10G, 10H). The M13 
ssDNA template contains multiple secondary structures, 
each of which could lead to a slowing of Pol δ4, as 
well as a potential for causing increased dissociation of 
Pol δ4. Thus, even modest effects of PDIP46 would be 
cumulative in the M13 template. The effects of PDIP46, 
observed over the period required for completion of the 
synthesis of the 7 kb full-length M13 DNA, would be 
much greater than those observed with the oligonucleotide 
substrate containing a single hairpin. This idea also 
explains why no significant stimulation was observed 
on the homopolymeric poly(dA) template. In addition, it 
is an attractive possibility that an interaction of PDIP46 
with both PCNA and Pol δ4 could stabilize the Pol δ4/
PCNA complex and contribute to the effects of PDIP46 
on processive synthesis as well as stimulation of Pol δ4 
synthesis through complex templates. Further studies are 
needed to clarify this issue, and await the development of 
mutants that can selectively affect PCNA and p50 binding 
to PDIP46.
It should be noted that while PDIP46 potently 
stimulates Pol δ4 synthesis on the M13 template, this 
should also be viewed in the context that even small 
secondary structures can considerably slow down Pol δ4 
synthesis. This also serves as a reminder that analyses of 
Pol δ4 activity on homopolymeric templates do not reflect 
those encountered on more complex templates. 
The extension of our findings using these substrates 
to DNA replication in human cells is that PDIP46 could 
enhance the rate of polymerization by Pol δ4 as well as its 
ability for bypass synthesis through secondary structures. 
While it is well accepted that DNA polymerases are 
impeded by secondary structures, there are few studies 
of the human DNA polymerases on such templates. 
Regions of stalling of Pol δ4 have been analyzed in the 
human FRA16D and FRA3B CSFs (common fragile site) 
[54, 55], sites of major chromosomal instability [56, 57]. 
The majority of the pause sites involve relatively small 
simple hairpins, such as the one used in this study, with 
loop regions of less than 10 nts and variable stem lengths 
[54, 55]. The human genome contains significant amounts 
of sequences that are the recognition sites for replication 
initiation, transcription, telomeres, amongst others, that 
pose challenges for human replicative polymerases. These 
DNA sequences form secondary structures, some as short 
hairpins and others as complex non-B DNA structures. 
Replication stalling caused by these sequences is now 
recognized as a major source of genomic instability 
that leads to cell death (aging) or transformation 
(tumorigenesis). These secondary structures can pose 
impediments to Pol δ, as well as lead to increased error 
rates [54, 55, 58-60].
Potential cellular roles of PDIP46 as a modulator 
of Pol δ4 functions at the replication fork
Our findings have shown that PDIP46 has a 
profound effect on Pol δ4, while having lesser effects on 
Pol δ3, particularly in the context of its effect on strand 
displacement and bypass of hairpin structures. Thus, this 
establishes a strong basis for a potential role of PDIP46 
in replication, specifically in facilitating synthesis through 
regions of secondary structures. Obviously, there are 
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a large number of cellular helicases that also could be 
involved in resolving complex structures. Nevertheless, 
the stimulation of Pol δ4 through secondary structures 
provides another model for an accessory protein that 
cumulatively could speed up Pol δ4 synthesis over long 
stretches of DNA. Further studies of the effects of PDIP46 
through more complex secondary structures such as 
trinucleotide repeats would add to our understanding of 
its role. Because PDIP46 appears to function by increasing 
the processivity of Pol δ4, it could act as a partner of 
Pol δ/PCNA at the replication fork as an “auxiliary” or 
“accessory” protein. While further research is needed to 
establish whether PDIP46 is a true accessory protein, and 
to establish its contributions to DNA replication in vivo, 
our present studies provide a reasonable foundation and 
rationale for explorations of this possibility. It is relevant 
that the in vitro activity of Pol δ is much slower than the 
estimated rate of in vivo synthesis, so that its function 
within the replisome might require additional protein 
factors. Assays of steady state rates of synthesis by Pol δ4 
in standard assays give rates of ca. 1 to 3nts/sec [38, 47], 
while the in vivo rate of synthesis in human cells has been 
estimated to be in the order of 30nts/sec in HeLa cells, 
as determined by BrdU labeling and DNA fiber analysis 
[61]. In yeast reconstituted replication systems, the rate 
of DNA synthesis is also about 10 fold lower than that in 
vivo [36, 62, 63]. 
There have been extensive studies in yeast by 
Figure 10: Diagrammatic summary of the effects of PDIP46 on Pol δ4 activity. (A., B.) PDIP46 stimulates Pol δ4 in the 
absence of PCNA, revealing a direct effect on Pol δ4. (C., D.) Pol δ4 synthesis in the presence of PCNA. Pol δ4 is strongly stimulated by 
PCNA alone, due to its conversion to a processive mode of synthesis, but this is further stimulated by PDIP46. (E., F.) PDIP46 stimulates 
PCNA-enabled synthesis through a hairpin secondary structure. (This is similar to effects in strand displacement, which are omitted). It is 
proposed that there is an additive effect of PDIP46 on Pol δ4 synthesis over that observed with oligonucleotides with a single secondary 
structure; this is illustrated in G. and H., to show the additive nature of the facilitation of synthesis when multiple stem-loop/hairpin 
structures are present. This provides a working hypothesis for the potent stimulation of Pol δ4 synthesis of full-length products in the M13 
assay by PDIP46. The increases in product formation are qualitatively represented by increases in weight of the dotted arrows for all panels. 
The direct effects of PDIP46 on Pol δ that indicate alteration in Pol δ function are shown by shadowing of the icons for Pol δ4 (B, D, F).
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several approaches that support the paradigm for a 
division of labor for Pol δ and Pol ε at the lagging and 
leading strands, respectively [36, 64-66], although a 
very recent study supports a major role for Pol δ in both 
leading and lagging strands [67]. Less direct experimental 
evidence is available in mammalian systems as to the 
designation of the roles of Pol δ and Pol ε. Subcellular 
localization studies of Pol δ and Pol ε in human cells 
during cell cycle progression as well as ChIP analyses 
have provided evidence that Pol δ and Pol ε may operate 
independently during S phase [68-70]. Our findings that 
PDIP46 accelerates Pol δ4 synthesis is consistent with 
a function as an accessory protein that allows Pol δ4 to 
participate in leading strand synthesis, together with Pol ε. 
Our current findings have highlighted the connection 
between strand displacement and the synthesis through the 
stem portion of stem-loop secondary structures; the lack of 
strand displacement activity by Pol δ3 also means that it 
is less able than Pol δ4 to negotiate stem-loop structures. 
Thus, we envisage that Pol δ4, with the assistance of 
PDIP46 may also be utilized in lagging strand synthesis to 
deal with such structures by switching with Pol δ3. This 
is consistent with findings that both Pol δ4 and Pol δ3 
are proficient in Okazaki fragment processing with Fen1 
and DNA ligase I [27]. Our studies would expand the 
latest model of the replication fork in higher eukaryotes 
which has Pol δ at both leading and lagging strands [71] 
to accommodate two forms of Pol δ and the participation 
of PDIP46.
PDIP46 as a multifunctional protein and its 
potential impact on genomic instability
Our studies have now defined PDIP46 as having 
the potential at the biochemical level to participate in 
DNA replication. At the same time, PDIP46 has been 
studied as the SKAR protein whose functions reside in 
the RRM domain that contains the interaction site for 
S6K1. SKAR functions provide a linkage to the mTOR 
pathway for control of cell growth via its recruitment with 
S6K1 to the exon junction complex where it plays roles 
in mRNA processing and translational control [29, 30]. 
SKAR has shown to play a key role in the IFN stimulated 
expression of genes that are critical for the antileukemic 
and antineoplastic responses in the use of IFNs in cancer 
immunotherapy [72]. This involves interferon (IFN)-α 
induced phosphorylation of SKAR by p90 ribosomal 
protein S6 kinase (RSK1).
 The roles of the C-terminal region may be even 
more complex, since PDIP46 also interacts with ERH 
(enhancer of rudimentary homolog) [73], a connection 
that provides linkages to cell cycle control and DNA 
replication. ERH is a transcriptional regulator that is 
required for the splicing of the mitotic motor protein 
CENP-E, and affects the expression of multiple cell cycle 
[74] and DNA damage response genes including ATR [75] 
as well as replication proteins [76]. 
Another important question that is raised is the 
potential role PDIP46 has on genomic stability, bearing 
in mind that PDIP46 has direct effects on Pol δ. As noted 
previously, these could lead to alterations of the kinetic 
constants of Pol δ that could affect its intrinsic processivity 
as well as fidelity, thereby raising the issue of PDIP46 
depletion or mutation as a potential source of genomic 
instability. While the study of PDIP46/SKAR functions 
are still at an early stage, it is nevertheless apparent that 
even within its currently known properties that it has 
the potential to play a role in the cancer process, either 
in terms of genomic stability directly by affecting DNA 
replication at the core level of synthesis and fidelity, or 
in terms of growth regulation and its role in transducing 
expression of replication and signaling proteins or anti-
neoplastic factors as described above. Highly pertinent 
to the issue of PDIP46/SKAR as a protein that may 
have potential as a target for oncogenesis are the recent 
studies that have identified POLDIP3 as one of a group 
of genes with altered copy number and expression in 
metastatic site-derived aggressive cells that exhibited 
high tumorigenic potential; moreover, reduced POLDIP3 
expression was correlated with decreased overall and 
relapse free survival in a cohort of 88 patients [77]. Along 
with this, immunohistochemical tissue staining for PDIP46 
in the Human Protein Atlas (http://www.proteinatlas.org) 
[78] shows a pattern of lowered expression of POLDIP3 in 
20 of the most common cancers. The COSMIC (catalogue 
of somatic mutations in cancer,) database (http://cancer.
sanger.ac.uk/cosmic) [79] also contains data on mutation 
spectra and altered copy number and expression of 
POLDIP3 in cancer tissues. These findings are consistent 
with a role of PDIP46 in the maintenance of genomic 
stability.
In summary, our current studies have provided the 
first analysis of the functional effects of PDIP46 on Pol δ 
activity. These add to the complexity of PDIP46 functions 
in relation to those associated with SKAR, but also 
provide insights and avenues for further dissection of their 
respective contributions to cellular functions in growth 
control and genomic stability. Our studies also point to 
caution in interpretation of the effects of PDIP46/SKAR 
depletion in cellular studies, because of its bifunctional 
nature. Thus, future studies in which expression of the 
two functional domains of PDIP46 in a PDIP46 null cell 
background are required. Overall, our studies add to the 
evidence that PDIP46/SKAR is a protein of significant 
interest in relation to genomic stability and as a potential 
marker for tumor progression.
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MATERIALS AND METHODS
Expression and purification of protein reagents 
For the pull-down assays, wild type GST-PDIP46, 
deletion mutants of GST-PDIP46, GST-p50 and truncated 
GST-p50 fragments were generated by PCR; the PCR 
generated fragments were digested with restriction 
endonucleases and subcloned in pGEX-5X-3 (Amersham 
Pharmacia Biotech,). His-tagged p50 was expressed in the 
PET33b vector [80]. His-tagged PDIP46 was expressed 
in the pTacTac vector with eight histidine residues added 
at its N-terminus. GST fusion or his-tagged proteins were 
expressed in E. coli BL21DE3 (pLysS), and purified 
by using either glutathione beads (GE Healthcare Life 
Sciences) or Ni-NTA agarose (Qiagen). 
Recombinant human Pol δ4 and Pol δ3 were 
expressed in insect cells and purified to near homogeneity 
[47]. PDIP46 was first expressed as the his-tagged-Sumo-
PDIP46 fusion protein using the pET Sumo vector (Life 
Technologies) and purified on Ni-NTA columns. The his-
Sumo tags were removed by Sumo protease, and PDIP46 
was further purified to near homogeneity by FPLC on 
Mono S 10/100 ion exchange columns (GE Healthcare 
Life Sciences). The PDIP46-∆RRM (deletion of residues 
280-351) and PDIP46-5A mutants were generated 
using QuikChange mutagenesis kits (Stratagene). 
Concentrations of Pol δ (p125 subunit content), PDIP46 
and its mutants were determined by SDS-PAGE with a 
range of concentrations of catalase as protein standard 
(Fig. S6, Supplementary Data). Human PCNA was 
expressed in E. coli and purified as previously described 
[81, 82]. 
GST pull-down assays
GST-PDIP46, GST-PDIP46 truncated deletion 
mutants and GST (control) were incubated with the same 
amounts of PCNA (or other test proteins) in 600 μl binding 
buffer (50 mM Tris-HCl, pH 7.8, 1 mM EDTA, 150 mM 
NaCl, 0.1% NP-40 and 0.2 mM phenylmethylsulfonyl 
fluoride). The reaction mixtures were incubated by gentle 
rocking for one hour at 4˚C. Packed glutathione beads 
were added (15 μl) and the suspension further rotated for 
another hour at the same temperature. The beads were 
spun down at 2,500 rpm for 5 minutes and washed 8 times 
with the binding buffer followed by suspension in 1 X 
SDS loading buffer. The bound proteins were analyzed 
by SDS-PAGE and Western blotted with antibody against 
PCNA or other test proteins. Similar protocols were used 
for other pull-down assays.
Western blotting, Co-immunoprecipitation and 
ChIP assays
Western blotting for Pol δ subunits was performed 
using antibodies against p125, p50, p68 and p12 [12, 14, 
19]. PCNA antibodies used were a monoclonal antibody 
[83,84] or PC10 (Santa Cruz Biotechnology). A rabbit 
polyclonal antibody against PDIP46 was generated by 
Proteintech Group. 
A549 human lung adenocarcinoma, HEK 293 and 
HeLa cells were obtained from ATCC and maintained 
according to protocols from the supplier [12, 14, 19]. The 
cells were lysed by sonication and centrifuged at 14,000 
rpm for 10 min. Primary antibodies were added overnight 
followed by addition of A/G agarose beads (Santa Cruz 
Biotechnology) for 1 hour, at 4° C. The beads were spun 
down and washed 8 times with RIPA buffer followed by 
suspension in 2X SDS loading buffer. The bound proteins 
were analyzed using SDS-PAGE and Western blotted for 
the test proteins. 
ChIP analysis was performed essentially as 
previously described [14]. A549 cells were grown on 15 
cm2 plates and cross-linked by addition of formaldehyde 
(1%) for 10 minutes at room temperature. The cross-
linking reaction was terminated by the addition of glycine 
to a final concentration of 0.25 M. Cells were harvested 
and ChIP assays using anti-p125 or control IgG were 
performed using a ChIP-IT Express Enzymatic Kit (Active 
Motif, Carlsbard, CA). Immunoprecipitated proteins were 
analyzed by SDS-PAGE and western blotted for PDIP46 
and p125. Antibodies to Mcm2 and Ctf4 used as positive 
controls were obtained from Santa Cruz Biotechnology.
Native gel electrophoresis
HEK 293 cells from five 75-cm2 flasks were 
harvested and extracts were prepared as described 
previously [9, 28]. Samples (150 µl, 10 mg/ml protein) 
were run on 5–15% gradient polyacrylamide gels with 
a 3.5% stacking gel at 4° C in the absence of SDS. 
Thyroglobulin (Mr 669,000), ferritin (Mr 440,000) and 
catalase (Mr 232,000) were used as markers. Gels were run 
until the migration of the protein standards was limited by 
pore size (18 h), as established by trial experiments. The 
proteins were transferred to nitrocellulose membranes and 
immunoblotted for p125 and PDIP46.
Assay for processive synthesis by Pol δ on singly 
primed M13 ssDNA
Assays using singly primed M13 DNA as the 
template were performed as previously described [12, 47]. 
Single stranded M13mp18 DNA (7250 bp, New England 
Biolabs, MA) was primed with a 20-mer oligonucleotide 
Oncotarget6310www.impactjournals.com/oncotarget
(5’-CTAGAGGATCCCCGGGTACC-3’) complementary 
to nucleotides 6262–6243 of the M13 genome. The 
standard reaction contained 40 mM Tris-HCl, pH 7.8, 1 
mM dithiothreitol, 0.2 mg/ml BSA, 10 mM MgCl2, 0.5 
mM ATP, 50mM NaCl, 250 μM each of dTTP, dCTP, and 
dGTP, and 25 μM cold dATP with 3 μCi of [α-32P]-dATP, 
2.5 nM primed M13 template, 6 nM human RFC, 6 nM 
PCNA, 250 nM RPA in a final volume of 16 µl. PCNA 
was first loaded onto the primed M13 DNA in the presence 
of RFC, RPA, ATP and Mg2+. Pol δ concentrations ranged 
from 5 nM to 60 nM as indicated in the figure legends. 
Pol δ was pre-incubated with PDIP46 on ice for 5 min 
prior to reaction. The reaction was started by the addition 
of Pol δ, or Pol δ with PDIP46. The reaction mixtures 
were incubated at 37 °C for the indicated times and were 
terminated by the addition of 120 mM EDTA. The reaction 
products were run on 1.2% alkaline agarose gels at 70 
V for 1.5 h. The gels were dried and visualized using a 
Molecular Dynamics Storm PhosphorImager system 
and quantified with ImageQuant software (Amersham 
Bioscience, NJ). 
Assays for primer extension and strand 
displacement synthesis using oligonucleotide 
substrates 
The primer/templates used for primer extension and 
strand displacement were as previously described [27]. 
The template for primer extension consisted of a 70mer: 
5’-biotin-CCT ATC TGA GCA CTA TCA TCG GTC GCA 
TCG TTG GCT GAA ATC GTG CTG TAG TGG CTG 
AAT CCC AAC CAA C-3’-biotin, where the ends were 
tagged with biotin. The 34mer primer sequence was 5’-
GTT GGT TGG GAT TCA GCC ACT ACA GCA CGA 
TTT C-3’. This primer was 5’ end-labeled with 32P and 
annealed to the template [27]. For strand displacement 
assays, a 31mer blocking oligonucleotide, 5’-ACG ATG 
CGA CCG ATG ATA GTG CTC AGA TAG G-3’ was also 
annealed downstream from the primer. Streptavidin was 
used to block the template ends and PCNA was loaded 
with RFC [27]. The hairpin substrate consisted of a 64mer 
template, 5’-GCG ATG CGA CCG ATG ACC CCC CCC 
TCA TCG GTC GCA TCG CTG GCT GTC AAG GTG 
CTG TAG TGG C-3’, where the underlined sequences are 
complementary and formed the hairpin. This was annealed 
to a 5’ -32P-end labeled 19mer primer, 5’-GCC ACT ACA 
GCA CCT TGA C-3’. 
Pol δ and PDIP46 were pre-incubated on ice for 5 
min before they were added to the reaction mixture. The 
reaction contained 50 nM or 100 nM of DNA, Pol δ and 
PDIP46 as indicated, 50 mM Tris-HCl pH 7.5, 50 mM 
NaCl, 2 mM dithiothreitol, 0.1mg/ml BSA, 5 mM MgCl2, 
and 0.15 mM dNTP. MgCl2 and dNTPs were added to 
the mixture to start the reactions, and equal volumes of 
gel loading buffer were added to stop the reactions. The 
loading buffer contained 50 mM EDTA, 95% formamide, 
0.01% bromophenol blue, 0.01% xylene cyanol. Reaction 
products were subjected to electrophoresis on sequencing 
gels (16–20% acrylamide/bisacrylamide 19:1 (Bio-
Rad), 7.4 M urea, 1 mM EDTA, 90 mM Tris–HCl and 
90 mM boric acid). Reaction products were visualized 
by phosphorimaging with a Molecular Dynamics Storm 
Phosphorimaging system and quantified with ImageQuant 
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